Filter
152
Filtered Results: 152
Text search:
Novartis
Featured
Recommendations
12
New Publications
30
Language
Document type
No document type
83
Studies & Reports
43
Guidelines
14
Strategic & Response Plan
6
Situation Updates
2
Fact sheets
2
Manuals
1
Resource Platforms
1
Countries / Regions
Global
10
Africa
6
Tanzania
6
South Africa
6
India
4
Russia
3
Indonesia
3
Ukraine
2
Ghana
2
Nigeria
2
Philippines
2
Cambodia
2
Latin America and the Carribbean
2
Germany
2
Western and Central Europe
2
Brazil
2
Nepal
1
Kenya
1
Sierra Leone
1
Chile
1
Malawi
1
Mozambique
1
Asia
1
Venezuela
1
Bangladesh
1
Namibia
1
Ethiopia
1
Authors & Publishers
Publication Years
Category
Non-communicable Diseases
12
Policies
10
Guidelines
8
Studies & Reports
8
Policies & Guidelines HIV & TB
6
Drugs & Medical Equipment
5
Pharmacy & Technologies
5
Leprosy
4
NTDs & Others
4
COVID-19
3
Health System Strengthening
3
Infection Control & Prevention (IPC)
2
Disabilities
2
Diabetes
1
Community Health
1
Virology
1
Pediatrics
1
Vaccine-preventable Diseases
1
Chagas
1
Clinical Guidelines
1
Women & Child Health
1
Community Health
1
Humanitarian Crisis
1
Leprosy
1
Other
1
WASH
1
Surgery & Anaesthesia
1
Maternal Health
1
Primary Health Care
1
Laboratory Quality Assurance
1
HIV & STI
1
Age & Elderly
1
Disease Prevention & Control
1
Global Health
1
TB
1
Toolboxes
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
14
Children/Adolescents Mental Disorders
14
Policies & Strategies
11
Prevention & Strategies
7
Prevention & Strategies
6
Prevention & Control
4
Essential Medicines
4
Prices and Patents
4
Studies & Reports
4
Neurological Disorders
4
National Policies
3
Attention deficit hyperactivity disorder (ADHD)
3
Country Guidelines
3
General
3
Country specific documents
3
Studies & Reports
3
Overview, Studies & Reports
3
Clinical Aspects & Diagnosis
3
Diagnosis
3
Drug resistant TB
3
Alzheimer's Disease & Dementia
3
Treatment & Clinical Management
3
Public Health
2
Long COVID/ Post-COVID Syndrome
2
One Health
2
Zoonoses
2
Studies & Reports
2
General
2
Human Rights & the Right to Health
2
Research & Access
2
Vision Loss & Blindness
2
Clinical Guidelines
1
Policies & Strategies
1
Assessment & Studies
1
General Reports
1
Agriculture & Veterinary
1
Clinical Guidelines
1
IPC
1
Background PTSD in children
1
Clinical Aspects, Treatment & Prevention
1
Vaccination
1
Adults
1
Diagnosis & Treatment PTSD in Children
1
Introduction to Global Health
1
Schizophrenia
1
Human Rights, Stigma & Discrimination
1
Inclusion
1
General Studies & Reports
1
IEC Materials
1
Latin America
1
Research
1
Mental Health Guidelines
1
Epilepsy
1
General
1
Studies
1
Health Personnel
1
Fair Allocation & Ethical Aspects
1
Research & Pipeline
1
Hygiene
1
Primary Care
1
Community Health Workers CHW
1
Pharmacy
1
Falsified & Substandard
1
Quality Assurance
1
Epilepsy
1
General Guidelines for Rational Use
1
Pharmaceutical Dosage Forms
1
Health Care Systems
1
General
1
Chagas
1
Strategies & Roadmaps
1
Studies & Reports
1
Studies & Reports
1
Foodborn trematodiasis
1
Studies & Reports
1
Prevention & Strategies
1
Information & Education Material (IEC)
1
Global Overview
1
General
1
others
1
Bipolar Affective Disorders
1
Assessment
1
Anxiety Disorders
1
Global Health Institutions and Stakeholders
1
Stigma
1
Antiretroviral Treatment ART
1
Guidelines CBR
1
Eastern Europe & Central Asia
1
Meningitis & Encephalitis
1
Neurological disorders, Others
1
The 2018 Access to Medicine Index finds that the pharmaceutical industry continues to mature in its approach to access to medicine, with models for good practice in areas such as access planning and licensing. GSK retains its No. 1 position, as Novartis moves up into 2nd. Takeda rises furthest in 20...
Introdução
Capítulo A.9
Edição em Português
Editor: Flávio Dias Silva.
Tradutores: Letícia Tomaz Oliveira, Luciano da Silva Quadros
Guidelines for Primary, Secondary and Tertiary Level Care
Introduction
Chapter A.9
Anxiety disorders
Chapter F.3
Troubles Anxieux
Chapitre F.3
Edition en français
Traduction : Alexis Revet
Sous la direction de : Jean-Philippe Raynaud Avec le soutien de la SFPEADA
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac...
(15 April 2020, BST 17:00 hours)
Actions Taken from Bangladesh Red Crescent Society (BDRCS):
9292 Number of staff and RCY/ CPP/ Camp/ Community volunteers being mobilized throughout the country.
10116 Set of PPE provided to individuals working on COVID-19 response.
130,851 Number of Total Peop...
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
Chagas disease affects approximately 6 million people, mainly in Latin America. Less than 1% of affected individuals receive proper antiparasitic treatment, and current drugs are inadequate to fight the entire spectrum of the disease. Against this background, Novartis is pursuing an end-to-end appro...
WHO promotes the inclusion of foodborne trematodiases among the targets of preventive chemotherapy interventions. With the aim of providing access to quality medicines, WHO has negotiated with Novartis Pharma AG whereby Novartis donates triclabendazole for the treatment of fascioliasis and paragonim...
Global progress against cardiovascular disease (CVD) is flatlining.
Though rates of CVD deaths globally have fallen in the last three
decades, this trend has begun to stall and, without concerted
efforts, is at risk of reversing.
In 2014, the World Heart Federation (WHF) launched
an initiative to develop a series of Roadmaps [1e6]. Their
aim is to identify potential roadblocks on the pathway to
effective prevention, detection, and management of cardiovascular disease (CVD), along with evidence-based
solutions to overcome...
This paper explores the angles and opportunities of digital health, with a look
at digital innovation and its potential to support patients with circulatory diseases.
In reviewing developments in the field, current applications as well as gaps, the paper aims to support policymakers in leveraging ...
Asthma is one of the neglected diseases in Africa with a high prevalence. Allergic fungal diseases have been reported to complicate asthma progression and treatment outcomes. However, data about fungal asthma and its associated complications are limited in Africa. We aimed to estimate the burden of ...
Chronic respiratory diseases, such as asthma and
chronic obstructive pulmonary disease, kill more than
four million people every year and affect hundreds
of millions more. These diseases erode the health
and well-being of the patients and have a negative
impact on families and societies. Women ...
Chronic respiratory diseases, such as asthma and
chronic obstructive pulmonary disease, kill more than
four million people every year and affect hundreds
of millions more. These diseases erode the health
and well-being of the patients and have a negative
impact on families and societies. Women ...
